Physician
TLC Pediatrics, PLLC
TLC Pediatrics, PLLC was paid $1.20M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoTLC PEDIATRICS, PLLC
CONWAY, AR 72034
CONWAY, AR 72034
33aNPI1649584038assigned 07/28/2010
33bProvider typePediatrics Physician
28Total paid$1.20M
24GClaims40,906
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Arkansas
Rank by total paid#22 of 108
Median peer was paid$225K
This provider vs. median5.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,594 | $80K | |
| 2019 | 4,935 | $132K | |
| 2020 | 4,409 | $111K | |
| 2021 | 6,691 | $192K | |
| 2022 | 8,176 | $259K | |
| 2023 | 7,460 | $226K | |
| 2024incomplete | 6,641 | $198K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 12,843 | 11,006 | $415K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 3,277 | 2,897 | $203K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 2,593 | 2,408 | $135K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 2,348 | 2,148 | $116K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.1% | 1,737 | 1,557 | $73K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.5% | 925 | 840 | $42K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.7% | 362 | 310 | $33K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 338 | 292 | $30K |
| 90686 | 1.9% | 2,070 | 1,873 | $23K | |
| 90670 | 1.3% | 1,515 | 1,431 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 1,515 | 728 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 1,100 | 781 | $14K |
38 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 308 | $10K |
| 90698 | <1% | 842 | $10K | |
| 90680 | <1% | 897 | $9K | |
| 87634 | <1% | 123 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 567 | $6K |
| 99460 | <1% | 43 | $4K | |
| 99173 | <1% | 341 | $4K | |
| 90633 | <1% | 362 | $4K | |
| 90697 | <1% | 296 | $4K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 48 | $3K |
| 90656 | <1% | 203 | $2K | |
| 90677 | <1% | 207 | $2K | |
| 90744 | <1% | 203 | $2K | |
| 99188 | <1% | 90 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,192 | $1K |
| 83655 | <1% | 102 | $1K | |
| 81002 | <1% | 369 | $1K | |
| 96127 | <1% | 437 | $907.45 | |
| 90685 | <1% | 88 | $822.16 | |
| 87807 | <1% | 64 | $741.57 | |
| 85018 | <1% | 248 | $647.54 | |
| 99381 | <1% | 15 | $549.09 | |
| 90710 | <1% | 44 | $513.77 | |
| 90696 | <1% | 41 | $500.63 | |
| 90707 | <1% | 31 | $328.50 | |
| 90716 | <1% | 30 | $315.36 | |
| 90700 | <1% | 29 | $302.22 | |
| 92552 | <1% | 15 | $277.20 | |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $219.40 |
| 90648 | <1% | 15 | $200.85 | |
| 90651 | <1% | 13 | $170.48 | |
| 90619 | <1% | 14 | $150.94 | |
| 94760 | <1% | 16 | $57.20 | |
| 91307 | <1% | 16 | $0.12 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 213 | $0.00 |
| 96160 | 0% | 2,444 | $0.00 | |
| 99072 | 0% | 267 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMPLIN, TERENCE (OWNER)